Toxoplasma gondii destroys Her2/Neu-expressing mammary cancer cells in vitro using a continuous feed medium approach

Esra Atalay Şahar1, Mert Döşkaya2, Muhammet Karakavuk3

  • 1Department of Parasitology, Faculty of Medicine, Ege University, Bornova, İzmir, Turkey. esra.atalay.sahar@gmail.com.

Abstract

Insights

Toxoplasma gondii tachyzoites effectively destroyed Her2/Neu-expressing mammary cancer cells in vitro. This study explored using protozoan parasites like T. gondii for cancer therapy research.

Area of Science:

  • Oncology
  • Parasitology
  • Cell Biology

Background:

  • Toxoplasma gondii is an opportunistic protozoan parasite.
  • Breast cancer remains a leading cause of cancer-related mortality in women.
  • Protozoan parasites are increasingly investigated for cancer therapy applications.

Purpose of the Study:

  • To investigate the efficacy of Toxoplasma gondii tachyzoites in destroying Her2/Neu-expressing mammary cancer cells (TUBO cells).
  • To evaluate a novel continuous feed medium approach for parasite-mediated cancer cell destruction.

Main Methods:

  • TUBO cells were cultured and inoculated with T. gondii tachyzoites at various ratios.
  • Two sets of experiments utilized different initial cell densities and parasite-to-cell ratios.
  • Culture supernatants were monitored, and tachyzoite counts were performed until cell destruction.

Main Results:

  • TUBO cells were destroyed within 8 to 25 days, depending on the experimental conditions.
  • T. gondii tachyzoite populations increased significantly, by 7- to 112,500-fold.
  • Parasite-induced destruction of mammary cancer cells was observed.

Conclusions:

  • T. gondii tachyzoites can effectively destroy Her2/Neu-expressing mammary cancer cells using a continuous feed medium.
  • This approach shows potential for future research in parasite-based cancer therapy.
  • Further investigation may contribute to novel strategies for saving cancer patients' lives.

Related Concept Videos